List of companies in The Column Group's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis. | ||||||
Kallyope is a New York City, New York based biotechnology company founded in 2015 developing therapeutics to improve human health by better understanding the gut-brain relationship. | ||||||
Gritstone Oncology is a Emeryville, California-based biotechnology company developing neoantigen-specific cancer immunotherapies. | ||||||
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics | ||||||
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells | ||||||
A company developing protein homeostasis therapies for oncology, immunology, and inflammation cases | ||||||
Neurona Therapeutics is a biotechnology company developing regenerative medicine products using stem cells for treating neurological disorders. | ||||||
Casma Therapeutics is a company that has a research community and uses its understanding of research to develop novel therapeutics to capture disease causing targets. | ||||||
A biotechnology company developing drugs for the treatment of metabolic diseases, cancer and inflammation | ||||||
Hexagon Bio is a technology company focused in oncology. | ||||||
REVOLUTION Medicines is a small Molecules founded in 2014. | ||||||
Tenaya Therapeutics is a cardiovascular Therapeutics founded in 2016 by Faraz Ali. | ||||||
ORIC Pharmaceuticals is a cancer, drug resistance founded in 2014 by Richard Heyman, Charles Sawyers and Scott Lowe. | ||||||
A company dedicated on the discovery and development of small molecule therapeutics to treat cancer | ||||||
Exonics Therapeutics was a Dallas-based biotechnology company developing gene editing therapies. | ||||||
Escient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018. | ||||||
Plexium is a small Molecules Targeting E3 Ligase founded in 2018. | ||||||
Surrozen is a wnt signaling antibodies. | ||||||
Synthekine is an engineered Cytokines. | ||||||
Small molecule therapies designed to reprogram RNA processing | ||||||
Accent Therapeutics is a RNA-modifying protein inhibitors founded in 2017 by Robert Copeland. | ||||||
A company that develops therapeutics for the treatment of cancer | ||||||
Cyterix Pharmaceuticals is a company developing cancer therapeutics. | ||||||
FLX Bio is a South San Francisco, California-based company. | ||||||
Nilo Therapeutics is a New York City-based company. |
